Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

Liu, Chang; M. Ginn, Helen; Dejnirattisai, Wanwisa; Supasa, Piyada; Wang, Beibei; Tuekprakhon, Aekkachai; Nutalai, Rungtiwa; Zhou, Daming; J. Mentzer, Alexander; Zhao, Yuguang; M. E. Duyvesteyn, Helen; López‐Camacho, César; Slon-Campos, Jose; S. Walter, Thomas; Skelly, Donal; A. Johnson, Síle; Ritter, Thomas; Mason, Chris; Ann Costa Clemens, Sue; Gomes Naveca, Felipe; Alves do Nascimento, Valdinete; Nascimento, Fernanda; Fernandes da Costa, Cristiano; Cristina Resende, Paola; Pauvolid‐Corrêa, Alex; Mendonça Siqueira, Marilda; Dold, Christina; Temperton, Nigel; Dong, Tao; J. Pollard, Andrew; C. Knight, Julian; W. Crook, Derrick; Lambe, Teresa; Clutterbuck, Elizabeth; Bibi, Sagida; Flaxman, Amy; Bittaye, Mustapha; Belij‐Rammerstorfer, Sandra; C. Gilbert, Sarah; Malik, Tariq; W. Carroll, Miles; Klenerman, Paul; Barnes, Eleanor; Dunachie, Susanna; L. Baillie, Vicky; Serafin, Natali; Ditse, Zanele; da Silva, Kelly; G. Paterson, Neil; A. Williams, Mark; R. Hall, David; A. Madhi, Shabir; C. Nunes, Marta; Goulder, Philip; E. Fry, Elizabeth; Mongkolsapaya, Juthathip; Ren, Jingshan; I. Stuart, David; Screaton, Gavin

doi:10.1016/j.cell.2021.06.020

Public

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

Published in Cell • Jun 17, 2021

Authors:

Chang Liu

Helen M. Ginn

Wanwisa Dejnirattisai

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has undergone progressive change, with variants conferring advantage rapidly becoming dominant lineages, e.g., B.1.617. With apparent increased transmissibility, variant B.1.617.2 has contributed to the current wave of infection ravaging t...

Subject

Biology

Neutralization

Virology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!